טוען...
Doxepin in children and adolescents with symptoms of insomnia: a single-center experience
STUDY OBJECTIVES: Pediatric insomnia is a widespread problem and especially difficult to manage in children with neurodevelopmental disorders. There are currently no US Food and Drug Administration–approved medications to use once first-line therapy fails. The objective of this study was to evaluate...
שמור ב:
| הוצא לאור ב: | J Clin Sleep Med |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Academy of Sleep Medicine
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849801/ https://ncbi.nlm.nih.gov/pubmed/32029069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5664/jcsm.8338 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|